The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to prospectively evaluate the effect of cancer pain management protocol on hospitalized cancer patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Cancer Center, Korea
• Collaborator: Janssen Korea, Ltd., Korea

Criteria

Inclusion Criteria:

• Hospitalized patient with the somatic and/or visceral pain having an untreated intensity greater than 3 on a 10 cm visual analog scale (VAS; 0 = no pain, 10 = unbearable pain)over the week prior to enrollment

• A minimum age of 18 years

Exclusion Criteria:

• Opioid intolerance

• No longer treatment for their underlying disease.

• Intracerebral primary or metastatic lesion

• Impaired sensory or cognitive function

• Pregnant or lactating woman

• Women of child bearing potential not using a contraceptive method

• Sexually active fertile men not using effective birth control during medication of study drug and up to 6 months after completion of study drug if their partners are women of child-bearing potential

• Any patients judged by the investigator to be unfit to participate in the study